EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges

Wangshu Li iD, Xiuying Wang, Xu Zhang iD, Aziz Ur Rehman Aziz iD, Daqing Wang

Biomolecules · 20.08.2024 · 14 (8) · 1035

DOI: 10.3390/biom14081035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.08.2024. Verfasst von Wangshu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: China Key Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, Dalian …. Hauptthemen laut MEDLINE: Killer Cells, Natural, Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian City Outstanding Young Science and Technology Talent Program, Dalian City High-Level Innovative Talent Team Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of chimeric antigen receptor (CAR) in natural killer (NK) cells for cancer therapy is gaining momentum, marking a significant shift in cancer treatment. This review aims to explore the potential of CAR-NK cell therapy in cancer immunotherapy, providing a fresh perspective. It discusses the innovative approaches in CAR-NK cell design and engineering, particularly targeting refractory or recurrent cancers. By comparing CAR-NK cells with traditional therapies, the review highlights their unique ability to tackle tumor heterogeneity and immune system suppression. Additionally, it explains how novel cytokines and receptors can enhance CAR-NK cell efficacy, specificity, and functionality. This review underscores the advantages of CAR-NK cells, including reduced toxicity, lower cost, and broader accessibility compared to CAR-T cells, along with their potential in treating both blood cancers and solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalNeoplasmsReceptors, Chimeric AntigenImmunotherapy, AdoptiveHumansAnimals

Stichwörter der Autor:innen

CAR-NK cell therapyImmunotherapytumor heterogeneity

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • China Key Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, Dalian 116012, China.
  • Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • The Second Affiliated Hospital of Harbin Medical University, Harbin 151801, China.

ORCID-Profile: Wangshu Li, Xu Zhang, Aziz Ur Rehman Aziz

Förderung

  • Dalian City Outstanding Young Science and Technology Talent Program
  • Dalian City High-Level Innovative Talent Team Project

Zitieren

APA

Li, W., Wang, X., Zhang, X., Aziz, A. U. R., & Wang, D. (2024). CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges. Biomolecules, 14(8), 1035. https://doi.org/10.3390/biom14081035

Vancouver

Li W, Wang X, Zhang X, Aziz AUR, Wang D. CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges. Biomolecules. 2024;14(8):1035. doi:10.3390/biom14081035

BibTeX
@article{Li2024,
  author = {Li, Wangshu and Wang, Xiuying and Zhang, Xu and Aziz, Aziz Ur Rehman and Wang, Daqing},
  title = {CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {1035},
  doi = {10.3390/biom14081035}
}
Kostenlos starten →